BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+27.34%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$563M
AUM Growth
+$563M
(+10%)
Cap. Flow
-$79.5M
Cap. Flow
% of AUM
-14.11%
Top 10 Holdings %
Top 10 Hldgs %
49.74%
Holding
64
New
14
Increased
14
Reduced
19
Closed
7
Top Buys
| 1 |
ACGN
Aceragen, Inc. Common Stock
ACGN
|
$7.87M |
| 2 |
NUVA
NuVasive, Inc.
NUVA
|
$7.35M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$6.3M |
| 4 |
TherapeuticsMD
TXMD
|
$6.24M |
| 5 |
SPNC
Spectranetics Corp
SPNC
|
$6M |
Top Sells
| 1 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$39.6M |
| 2 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
$14M |
| 3 |
Integra LifeSciences
IART
|
$11.3M |
| 4 |
LCI
Lannett Company, Inc.
LCI
|
$11.2M |
| 5 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$9.74M |
Sector Composition
| 1 | Healthcare | 77.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Assertio
ASRT
$80.4M
| $42M | 7.46% | 5,622,023 | – | – |
|
2
AngioDynamics
ANGO
$417M
| $37.3M | 6.62% | 2,826,651 +100,000 | +4% | +$1.32M |
|
|
NTUS
3
DELISTED
Natus Medical Inc
NTUS
| $35.7M | 6.35% | 2,520,992 -70,000 | -3% | -$993K |
|
|
LCI
4
DELISTED
Lannett Company, Inc.
LCI
| $28.6M | 5.07% | 1,308,561 -513,697 | -28% | -$11.2M |
|
|
NVDQ
5
DELISTED
Novadaq Technologies Inc.
NVDQ
| $27.9M | 4.95% | 1,687,090 -296,352 | -15% | -$4.9M |
|
|
AVDL
6
Avadel Pharmaceuticals
AVDL
$1.43B
| $24.7M | 4.39% | 3,767,911 +628,780 | +20% | +$4.12M |
|
7
Teva Pharmaceuticals
TEVA
$21.1B
| $24.2M | 4.3% | 641,736 -221,500 | -26% | -$8.37M |
|
8
Emergent Biosolutions
EBS
$443M
| $20.5M | 3.63% | 1,074,248 | – | – |
|
|
TTPH
9
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $20.4M | 3.62% | 1,793,328 +365,014 | +26% | +$4.15M |
|
|
IPXL
10
DELISTED
Impax Laboratories, Inc.
IPXL
| $18.9M | 3.35% | 922,543 -476,000 | -34% | -$9.74M |
|
|
ANAC
11
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $18.5M | 3.28% | 1,737,669 +13,641 | +0.8% | +$145K |
|
|
PGNX
12
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $17.5M | 3.1% | 3,479,348 -21,267 | -0.6% | -$107K |
|
|
CEMP
13
DELISTED
Cempra, Inc.
CEMP
| $16M | 2.84% | 1,391,357 -163,790 | -11% | -$1.88M |
|
14
Alkermes
ALKS
$4.78B
| $15.1M | 2.69% | 450,000 -150,000 | -25% | -$5.04M |
|
|
AUXL
15
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $14.8M | 2.62% | 811,100 +11,100 | +1% | +$202K |
|
|
NPSP
16
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $14.4M | 2.55% | 451,597 -1,245,157 | -73% | -$39.6M |
|
17
Rigel Pharmaceuticals
RIGL
$697M
| $12.8M | 2.27% | 3,565,819 +515,819 | +17% | +$1.85M |
|
|
BDSI
18
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $11.5M | 2.05% | 2,122,054 | – | – |
|
|
DSCI
19
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $9.55M | 1.7% | 771,598 -3,402 | -0.4% | -$42.1K |
|
|
20
Integra LifeSciences
IART
$1.18B
| $8.91M | 1.58% | 221,391 -281,523 | -56% | -$11.3M |
|
|
SPNC
21
DELISTED
Spectranetics Corp
SPNC
| $8.33M | 1.48% | 495,833 +357,113 | +257% | +$6M |
|
|
ACGN
22
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $7.87M | 1.4% | +4,525,000 | New | +$7.87M |
|
23
DURECT Corp
DRRX
$59.6M
| $7.55M | 1.34% | 5,632,977 -366,123 | -6% | -$491K |
|
24
AtriCure
ATRC
$1.84B
| $7.44M | 1.32% | 677,543 -114,298 | -14% | -$1.25M |
|
|
NUVA
25
DELISTED
NuVasive, Inc.
NUVA
| $7.35M | 1.3% | +300,000 | New | +$7.35M |
|